Enovix Corp. (ENVX)
3.42
+0.06
(+1.79%)
USD |
NASDAQ |
Aug 31, 12:00
Enovix Research and Development Expense (TTM) : 106.81M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 106.81M |
| March 31, 2026 | 110.51M |
| December 31, 2025 | 109.92M |
| September 30, 2025 | 104.27M |
| June 30, 2025 | 100.31M |
| March 31, 2025 | 101.23M |
| December 31, 2024 | 111.60M |
| September 30, 2024 | 124.17M |
| June 30, 2024 | 113.46M |
| March 31, 2024 | 100.94M |
| December 31, 2023 | 88.39M |
| Date | Value |
|---|---|
| September 30, 2023 | 69.36M |
| June 30, 2023 | 69.80M |
| March 31, 2023 | 69.07M |
| December 31, 2022 | 58.05M |
| September 30, 2022 | 54.94M |
| June 30, 2022 | 51.30M |
| March 31, 2022 | 44.99M |
| December 31, 2021 | 37.85M |
| September 30, 2021 | 30.41M |
| June 30, 2021 | 23.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amprius Technologies, Inc. | 13.16M |
| Eos Energy Enterprises, Inc. | 35.73M |
| ESS Tech, Inc. | 7.514M |
| Ultralife Corp. | 10.95M |
| Bimergen Energy Corp. | -- |